Transcat, Inc. (NASDAQ:TRNS) has earned a consensus broker rating score of 2.00 (Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating. Transcat’s rating score has declined by 33.3% in the last 90 days as a result of a number of analysts’ upgrades and downgrades.
Brokerages have set a 12 month consensus target price of $31.00 for the company and are anticipating that the company will post $0.25 EPS for the current quarter, according to Zacks. Zacks has also given Transcat an industry rank of 78 out of 256 based on the ratings given to its competitors.
TRNS has been the topic of a number of recent analyst reports. ValuEngine upgraded shares of Transcat from a “hold” rating to a “buy” rating in a report on Monday, February 4th. Zacks Investment Research upgraded shares of Transcat from a “hold” rating to a “buy” rating and set a $28.00 price target on the stock in a report on Saturday, May 25th.
In other news, Director Carl E. Sassano sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $24.85, for a total value of $124,250.00. Following the sale, the director now directly owns 71,484 shares in the company, valued at approximately $1,776,377.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 8.80% of the stock is currently owned by company insiders.
Several large investors have recently added to or reduced their stakes in TRNS. Marshall Wace North America L.P. boosted its stake in Transcat by 157.5% during the 1st quarter. Marshall Wace North America L.P. now owns 1,545 shares of the scientific and technical instruments company’s stock worth $36,000 after purchasing an additional 945 shares during the last quarter. BlueCrest Capital Management Ltd acquired a new stake in Transcat during the 1st quarter worth $237,000. Morgan Stanley acquired a new stake in Transcat during the 1st quarter worth $36,000. ExodusPoint Capital Management LP acquired a new stake in Transcat during the 1st quarter worth $593,000. Finally, Punch & Associates Investment Management Inc. boosted its stake in Transcat by 0.8% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 340,398 shares of the scientific and technical instruments company’s stock worth $7,822,000 after purchasing an additional 2,700 shares during the last quarter. Institutional investors and hedge funds own 62.06% of the company’s stock.
Transcat stock traded up $0.05 during midday trading on Monday, hitting $24.85. 37,300 shares of the company’s stock were exchanged, compared to its average volume of 22,944. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.16 and a quick ratio of 1.45. Transcat has a 12 month low of $17.30 and a 12 month high of $26.96. The stock has a market cap of $178.79 million, a price-to-earnings ratio of 26.02, a PEG ratio of 2.98 and a beta of 0.78.
Transcat (NASDAQ:TRNS) last issued its earnings results on Tuesday, May 21st. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.09. Transcat had a net margin of 4.44% and a return on equity of 13.05%. The company had revenue of $44.49 million for the quarter, compared to analysts’ expectations of $41.90 million. On average, equities analysts expect that Transcat will post 1.04 earnings per share for the current year.
Transcat Company Profile
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Read More: Average Daily Trade Volume – What It Means In Stock Trading
Get a free copy of the Zacks research report on Transcat (TRNS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.